Ingevity NGVT Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $1.21B-2.0% | $1.2B-9.5% | $1.21B+13.6% | $1.21B+2.8% | $1.24B-2.5% | ||
| $735.3M-4.4% | $729.7M-16.5% | $725.8M— | $728.8M— | $769M— | ||
| $476M+2.0% | $471.5M+3.8% | $483.6M+24.9% | $481.3M+25.2% | $466.6M+12.6% | ||
| 39.3%+1.5pp | 39.3%+5.0pp | 40%+3.6pp | 39.8%+7.1pp | 37.8%+5.1pp | ||
| $28.9M+7.0% | $29.2M+9.0% | $28.3M+34.1% | $27.5M+21.1% | $27M+15.4% | ||
| $170.6M+7.0% | $171.8M+4.2% | $168.5M+13.9% | $162.3M+8.1% | $159.5M-0.6% | ||
| $81.8M-18.8% | $78.3M-19.9% | $110.7M+25.4% | $105.3M+18.3% | $100.7M+11.1% | ||
| -$155.7M— | -$148.3M— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$127.8M+65.5% | -$167.1M+62.6% | -$82.5M+85.4% | -$233.2M+45.9% | -$370.4M-230% | ||
| -10.6%+19.4pp | -13.9%+19.7pp | -6.8%+46.1pp | -19.3%+17.4pp | -30%-21.1pp | ||
| -$3.52+65.5% | -$4.62+62.4% | -$2.28+85.3% | -$6.40+45.9% | -$10.19-233% | ||
| $30.3M— | $36.4M— | —— | —— | —— | ||
| 2.5%— | 3%— | —— | —— | —— | ||
| -$73.9M— | -$70M— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Ingevity's revenue?
- Ingevity (NGVT) generated $1.2B in revenue over the trailing twelve months, down 2.0% year over year.
- Is Ingevity profitable?
- Ingevity is not currently profitable: it reported a net loss of $127.8M over the trailing twelve months, a -10.6% net margin.
- What is Ingevity's earnings per share?
- Ingevity's diluted EPS over the trailing twelve months is $-3.52.
- Where does Ingevity's income statement data come from?
- Every line is extracted from Ingevity's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
